开放性骨折浅表手术部位感染抗生素治疗成功率分析
基于FLOW试验数据的二次分析纳入168例开放性骨折后12个月内诊断浅表SSI的患者,其中139例仅用抗生素治疗。抗生素治疗使70%(97/139)的浅表SSI消退,30%(42/139)未消退。校正混杂因素后,随访中较晚诊断的浅表SSI与抗生素治疗未消退相关(每随访一周OR 1.05,95%CI 1.004-1.009,p=0.03)。
要点
- 开放性骨折后浅表SSI仅用抗生素治疗,70%可消退。
- 30%浅表SSI抗生素治疗未消退,需手术或随访时未愈。
- 较晚诊断的浅表SSI与抗生素治疗失败独立相关。
核心结论
- 对FLOW数据的前瞻性二次分析提示,开放性骨折伤口后浅表SSI尤其早期诊断时,单用抗生素可作为合适的治疗选择。
- 需更长随访研究以明确浅表SSI自然史及潜在休眠或亚临床感染,帮助临床决策。
研究设计与样本
- FLOW试验数据集二次分析,FLOW试验纳入2445例手术治疗的开放性骨折患者。
- 纳入骨折后12个月内诊断并采用非手术管理的浅表SSI参与者168例,其中83%(139例)仅用抗生素治疗。
- 139例分为抗生素治疗消退组97例和未消退组42例,未消退定义为接受手术治疗或末次随访(骨折后12个月)时SSI未愈。
- 采用logistic二元回归分析,基于生物学 rationale 和既往证据预先确定13个潜在因素(对应14个水平)纳入模型。
- 证据等级为Level III,治疗性研究。
主要发现
- 抗生素治疗使70%(97/139)的浅表SSI消退,30%(42/139)未消退。
- 校正年龄、骨折严重程度、损伤至初次手术冲洗清创时间等混杂因素后,随访中较晚诊断的浅表SSI与抗生素未消退SSI相关(每随访一周OR 1.05,95%CI 1.004-1.009,p=0.03)。
- 性别、骨折类型和伤口大小与抗生素未消退SSI无关。
- 抗生素治疗消退组中92%(89/97)完成随访,6%(6/97)12个月前失访,1%(1/97)12个月前退出,1%(1/97)12个月前死亡。
- 抗生素治疗未消退组中90%(38/42)完成随访,7%(3/42)12个月前失访,2%(1/42)12个月前退出。
临床怎么用
- 开放性骨折后浅表SSI可考虑单用抗生素治疗,尤其早期诊断时。
- 较晚诊断的浅表SSI抗生素治疗失败风险较高,需更密切监测或考虑其他处理。
局限性
- 为FLOW试验数据的二次分析,可能存在混杂和选择偏倚。
- 需更长随访研究以明确浅表SSI自然史及潜在休眠或亚临床感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although many studies report the incidence and prevalence of surgical site infections (SSIs) after open fractures, there is limited information on the treatment and subsequent outcomes of superficial SSIs in patients with open fractures. Additionally, clinical studies describing the factors that are associated with persistent infection after nonoperative treatment with antibiotics for patients with superficial SSIs are lacking. QUESTIONS/PURPOSES: Therefore, we asked: (1) What proportion of patients with superficial SSIs after open fracture treatment developed persistent infection after nonoperative treatment (that is, treatment with antibiotics alone)? (2) What risk factors are associated with SSIs that do not resolve with nonoperative (antibiotic) treatment? As a secondary objective, we planned to analyze the microbiological information about participants wound cultures, when these were available, and the proportion of positive cultures for patients whose SSIs were not resolved by antibiotics alone. METHODS: This is a secondary analysis of the Fluid Lavage of Open Wounds (FLOW) trial dataset. The FLOW trial included 2445 patients with operatively managed open fractures. FLOW participants who had a nonoperatively managed superficial SSI diagnosed in the 12 months post-fracture were included in this analysis. Superficial SSIs were diagnosed in 168 participants within 12 months of their fracture. Of these, 83% (139) had their superficial SSI treated with antibiotics alone. Participants were grouped into two categories: (1) 97 participants whose treatment with antibiotics alone resolved the superficial SSI and (2) 42 participants whose treatment with antibiotics alone did not resolve the SSI (defined as undergoing surgical management or the SSI being unresolved at latest follow-up [12-months post-fracture for the FLOW trial]). Of the participants whose treatment with antibiotics alone resolved the SSI, 92% (89 of 97) had complete follow-up, 6% (6 of 97) were lost to follow-up before 12 months, 1% (1 of 97) withdrew consent from the study before 12 months, and 1% (1 of 97) experienced mortality before 12 months. Of the participants whose treatment with antibiotics alone did not resolve the SSI, 90% (38 of 42) had complete follow-up, 7% (3 of 42) were lost to follow-up before 12 months, and 2% (1 of 42) withdrew consent from the study before 12 months. A logistic binary regression analysis was conducted to identify factors associated with persistent infection despite superficial SSI antibiotic treatment. Based on biologic rationale and previous evidence, we identified a priori 13 potential factors (corresponding to 14 levels) to be included in the regression model. RESULTS: The antibiotic treatment resolved the superficial SSI in 70% (97 of 139) of patients and did not resolve the SSI in 30% (42 of 139). After controlling for potential confounding variables, such as age, fracture severity, and time from injury to initial surgical irrigation and débridement, superficial SSIs diagnosed later in follow-up were associated with antibiotics not resolving the SSI (odds ratio 1.05 [95% CI 1.004 to 1.009] for every week of follow-up; p = 0.03). Sex, fracture pattern, and wound size were not associated with antibiotics not resolving the SSI. CONCLUSIONS: Our secondary analysis of prospectively collected FLOW data suggests that antibiotics alone can be an appropriate treatment option when treating superficial SSIs after an open fracture wound, especially when promptly diagnosed. Further research with longer follow-up time is needed to better identify the natural history of superficial SSIs and possibly some dormant or subclinical infections to help clinicians in the treatment decision-making process. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Prada C, Tanner SL, Marcano-Fernández FA, et al. How Successful Is Antibiotic Treatment for Superficial Surgical Site Infections After Open Fracture? A Fluid Lavage of Open Wounds (FLOW) Cohort Secondary Analysis. Clin Orthop Relat Res. 2020. PMID: 32412929. doi:10.1097/CORR.0000000000001293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。